8-KOther EventsExhibits & Filings

PROCTER & GAMBLE Co 8-K Report, Corporate Update (May 3, 2017)

Filed May 3, 2017For Securities:PG

Summary

Procter & Gamble Company (PG) has filed an 8-K report on May 3, 2017, detailing the successful closure of an underwritten public offering. The company issued a total of £750,000,000 in aggregate principal amount of notes, split between £375,000,000 of 1.375% Notes due May 3, 2025, and £375,000,000 of 1.800% Notes due May 3, 2029. This offering was conducted under the company's existing Form S-3 Registration Statement. The primary takeaway for investors is the company's successful access to debt markets to raise capital. The issuance of these notes provides the company with funds that can be used for various corporate purposes, potentially including working capital, general corporate operations, or strategic investments. The specific interest rates and maturity dates offer insights into the cost of borrowing and the company's long-term debt structure.

Key Highlights

  • 1PG closed an underwritten public offering of £750,000,000 in aggregate principal amount of debt.
  • 2The offering consisted of two tranches: £375,000,000 of 1.375% Notes due May 3, 2025.
  • 3The second tranche consisted of £375,000,000 of 1.800% Notes due May 3, 2029.
  • 4The issuance was conducted under the company's previously filed Form S-3 Registration Statement.
  • 5Legal opinions and consents from internal counsel (Hatsuki Miyata) and external counsel (Fried, Frank, Harris, Shriver & Jacobson LLP) are included as exhibits.
  • 6The event date for this disclosure is May 2, 2017, with the filing date of May 3, 2017.

Frequently Asked Questions

The 8-K filing does not specify the exact use of proceeds for these notes. However, typically, companies issue debt to fund general corporate purposes, which can include working capital, capital expenditures, acquisitions, or refinancing existing debt.

Procter & Gamble raised a total of £750,000,000 in aggregate principal amount of notes.

The notes were issued in two tranches: £375,000,000 of 1.375% Notes due May 3, 2025, and £375,000,000 of 1.800% Notes due May 3, 2029.

This filing primarily reports a financing activity (debt issuance) rather than providing a comprehensive financial health assessment. The issuance of debt can be a sign of the company's ability to access capital markets, but investors should refer to the company's full financial statements (e.g., in 10-Q or 10-K filings) for a complete picture of its financial health.